A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and Solution

Clinical trial NCT02446171 · COMPLETED

Trial details

NCT number: NCT02446171
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioavailability Healthy Subjects

Start date: 2015-05-01
Primary completion: 2015-07-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.